SCHEMBL3772058

SCHEMBL3772058

S=C([S-])NN1CCOCC1.[Na+]

nearest known ligand 0.95

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA12 known ✓ O43570 7/20 0.95
CA1 known ✓ P00915 7/20 0.95
CA2 known ✓ P00918 6/20 0.95
CA9 Q16790 7/20 0.95
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.42
RAB9A P51151 2/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
GAA P10253 2/20 0.40
MAPT P10636 1/20 0.40
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL14843848 0.95 CA12 (1.00) CA12CA1CA9CA2ALDH1A1
SCHEMBL5826309 0.95 CA12 (0.95) CA12CA1CA9CA2ALDH1A1
SCHEMBL6060070 0.95 CA12 (0.95) CA12CA1CA9CA2ALDH1A1
SCHEMBL3879352 0.78 CA2 (0.60) CA12CA1CA9CA2ALDH1A1
SCHEMBL11174169 0.78 CA12 (0.67) CA12CA1CA9CA2ALDH1A1
SCHEMBL3077426 0.76 CA12 (0.64) CA12CA1CA9CA2ALDH1A1
SCHEMBL6515026 0.76 CA2 (0.58) CA12CA1CA9CA2ALDH1A1
SCHEMBL1267862 0.74 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL3071219 0.74 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL10742927 0.74 CA12 (0.61) CA12CA1CA9CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117861863-A Inhibitor of non-molybdenum sulfide ore and application of inhibitor in metal sulfide ore flotation separation 江西理工大学 2024-04-12 CN disclosed
EP-1554241-B1 S-(ALPHA,ALPHA'-DISUBSTITUTED-ALPHA\"-ACETIC ACID) SUBSTITUTED DITHIOCARBONATE DERIVATIVES FOR CONTROLLED RADICAL POLYMERISATIONS, PROCESS AND POLYMERS MADE THEREFROM LUBRIZOL ADVANCED MAT INC (US) 2015-03-18 EP disclosed
WO-2013050426-A1 CARBONIC ANHYDRASE INHIBITOR COMPRISING A DITHIOCARBAMATE UNIVERSITETET I OSLO (NO) 2013-04-11 WO disclosed
US-7851582-B2 S-(α, α′-disubstituted-α″-acetic acid)—substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom LUBRIZOL ADVANCED MATERIALS, INC. (US) 2010-12-14 US disclosed
US-7498456-B2 S-(α, α′-disubstituted-α″-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerization, process and polymers made therefrom LUBRIZOL ADVANCED MATERIALS, INC. (US) 2009-03-03 US disclosed
US-20080214773-A1 S-(Alpha, Alpha'-Disubstituted-Alpha\"-Acetic Acid) - Substituted Dithiocarbonate Derivatives For Controlled Radical Polymerizations, Process and Polymers Made Therefrom LAI JOHN TA-YUAN 2008-09-04 US disclosed
US-7335788-B2 S-(α, α′-disubstituted-α″-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom LUBRIZOL ADVANCED MATERIALS, INC. (US) 2008-02-26 US disclosed
US-20070167571-A1 S-(Alpha, Alpha'-Disubstituted-Alpha\"-Acetic Acid) Substituted Dithiocarbonate Derivatives for Controlled Radical Polymerizations, Process and Polymers Made Therefrom LUBRIZOL ADVANCED MATERIALS, INC. 2007-07-19 US disclosed
US-7205368-B2 S-(α, α′-disubstituted-α′ ′-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom NOVEON, INC. (US) 2007-04-17 US disclosed
WO-2005080326-A1 TOUGHENED VINYL ESTER RESINS NOVEON IP HOLDINGS CORP. (US) 2005-09-01 WO disclosed
EP-1453841-A1 TECHNETIUM OR RHENIUM COMPLEXES, RADIOPHARMACEUTICAL PRODUCTS COMPRISING THEM SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-08 EP disclosed
WO-2004037780-A1 S-(a, a’ -DISUBSTITUTED-a” -ACETIC ACID) SUBSTITUTED DITHIOCARBONATE DERIVATIVES FOR CONTROLLED RADICAL POLYMERIZATIONS, PROCESS AND POLYMERS MADE THEREFROM NOVEON IP HOLDINGS CORP. (US) 2004-05-06 WO disclosed
US-20040073056-A1 S-(alpha, alpha'-disubstituted-alpha\"-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom LUBRIZOL ADVANCED MATERIALS, INC. 2004-04-15 US disclosed
EP-1089723-A4 THERAPEUTIC METHODS EMPLOYING DISULFIDE DERIVATIVES OF DITHIOCARBAMATES AND COMPOSITIONS USEFUL THEREFOR MEDINOX INC (US) 2003-07-16 EP disclosed
US-20030120101-A1 S-(alpha, alpha'-disubstituted-alpha' '-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom LUBRIZOL ADVANCED MATERIALS, INC. 2003-06-26 US disclosed
WO-2003044031-A1 TECHNETIUM OR RHENIUM COMPLEXES, RADIOPHARMACEUTICAL PRODUCTS COMPRISING THEM SCHERING AKTIENGESELLSCHAFT (DE) 2003-05-30 WO disclosed
CN-1315856-A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor MEDINOX INC (US) 2001-10-03 CN disclosed
EP-1089723-A1 THERAPEUTIC METHODS EMPLOYING DISULFIDE DERIVATIVES OF DITHIOCARBAMATES AND COMPOSITIONS USEFUL THEREFOR Medinox, Inc. (US) 2001-04-11 EP disclosed
WO-1999066918-A9 THERAPEUTIC METHODS EMPLOYING DISULFIDE DERIVATIVES OF DITHIOCARBAMATES AND COMPOSITIONS USEFUL THEREFOR MEDINOX INC (US) 2000-03-30 WO disclosed
WO-1999066918-A1 THERAPEUTIC METHODS EMPLOYING DISULFIDE DERIVATIVES OF DITHIOCARBAMATES AND COMPOSITIONS USEFUL THEREFOR MEDINOX, INC. (US) 1999-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030120101-A1 S-(alpha, alpha'-disubstituted-alpha' '-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom TST, SRM, ACMSD CA12 1776/4885CA1 1482/4885CA2 1854/4885
US-20080214773-A1 S-(Alpha, Alpha'-Disubstituted-Alpha\"-Acetic Acid) - Substituted Dithiocarbonate Derivatives For Controlled Radical Polymerizations, Process and Polymers Made Therefrom TST, ACMSD, ETFA CA12 1922/4885CA1 1544/4885CA2 1798/4885
US-20070167571-A1 S-(Alpha, Alpha'-Disubstituted-Alpha\"-Acetic Acid) Substituted Dithiocarbonate Derivatives for Controlled Radical Polymerizations, Process and Polymers Made Therefrom TST, ACMSD, SRM CA12 1670/4885CA1 1345/4885CA2 1681/4885
US-20040073056-A1 S-(alpha, alpha'-disubstituted-alpha\"-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom TST, ACMSD, SRM CA12 1670/4885CA1 1345/4885CA2 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.